PET Imaging in Parkinson Disease Dementia



Status:Active, not recruiting
Conditions:Parkinsons Disease, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:50 - Any
Updated:1/10/2019
Start Date:August 2006
End Date:July 2030

Use our guide to learn which trials are right for you!

Investigations of Dementia in Parkinson Disease

The purpose of this study is to use a brain imaging method called PIB PET to determine
dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is
to be able to identify individuals with PD who are at risk of developing dementia, and to
distinguish the underlying cause of dementia.

The purpose of this study is to use a brain imaging method called PIB PET to determine
dementia subtypes in patients with Parkinson's disease. The ultimate goal of this project is
to be able to identify individuals with PD who are at risk of developing dementia, and to
distinguish the underlying cause of dementia. We will be including both PD and normal
subjects in this study. This a long term study and we are considering including a total of
320 participants in this protocol.

Inclusion Criteria:

- PD patients must exhibit three of the following cardinal signs: rest tremor, rigidity,
bradykinesia, or postural instability; or two of these features with one of the first
three displaying asymmetry.

Exclusion Criteria:

- history of head trauma, major neurological or psychiatric diseases other than
Parkinson disease and dementia, e.g. stroke, multiple sclerosis, depression or
schizophrenia

- severe systemic diseases

- inability to lie still for 90 minutes

- metallic implants, pacemakers, or any other contraindication to MRI

- refusal to consent to brain donation
We found this trial at
1
site
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials